SEC FILLINGS DISCLOSED/ Jan 28, $BridgeBio Pharma (BBIO.US)$ Director KUMAR HALDEA REVOCABLE TRUST U/A DTD 12/19/2018 intends to sell 600K shares of its common stock on Jan 28, with a total market value of approximately $22 million.
KUMAR HALDEA REVOCABLE TRUST U/A DTD 12/19/2018 has reduced shareholding in $BridgeBio Pharma (BBIO.US)$ by 27,389 shares since Nov 19, 2024, with a total value of approximately $613.83K.
What is Form 144?
Form 144: Notice of Proposed Sale of Securities is a document issued by the Securities and Exchange Commission (SEC). Individuals such as executive officers and affiliates of a US-listed company must submit this form to the SEC when they intend to sell more than 5,000 shares or units of that company's stock, or if the sale price adds up to more than $50,000 in any three-month period. This regulation is known as Rule 144, under the Securities Act of 1933.
Comment(0)
Reason For Report